PharmaCyte Biotech, Inc. (PMCB)

NASDAQ: PMCB · Real-Time Price · USD

1.020

-0.030 (-2.86%)

At close: Jun 27, 2025, 4:00 PM

1.030

+0.010 (0.98%)

After-hours: Jun 27, 2025, 4:00 PM EDT

PharmaCyte Biotech Income Statement

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jan '25 Jan 31, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021	Apr '20 Apr 30, 2020	2015 - 2019
Selling, General & Admin	4.1	6.11	5.99	3.7	2.71	3.53	Upgrade
Research & Development	0.41	0.41	0.47	0.69	0.92	0.3	Upgrade
Operating Expenses	4.5	6.52	6.46	4.39	3.62	3.83	Upgrade
Operating Income	-4.5	-6.52	-6.46	-4.39	-3.62	-3.83	Upgrade
Interest Expense	-	-	-	-0	-0	-0	Upgrade
Interest & Investment Income	1.93	3.4	1.94	0.16	-	-	Upgrade
Other Non Operating Income (Expenses)	13.12	5.45	0.2	-0	-0	-0	Upgrade
EBT Excluding Unusual Items	10.55	2.33	-4.32	-4.24	-3.63	-3.83	Upgrade
Asset Writedown	-2	-2	-	-	-	-	Upgrade
Other Unusual Items	-	-	-	-	0.08	-	Upgrade
Pretax Income	20.25	0.33	-4.32	-4.24	-3.55	-3.83	Upgrade
Net Income	20.25	0.33	-4.32	-4.24	-3.55	-3.83	Upgrade
Preferred Dividends & Other Adjustments	10.28	17.57	-	-	-	-	Upgrade
Net Income to Common	9.98	-17.24	-4.32	-4.24	-3.55	-3.83	Upgrade
Shares Outstanding (Basic)	8	10	19	16	1	1	Upgrade
Shares Outstanding (Diluted)	8	10	19	16	1	1	Upgrade
Shares Change (YoY)	-35.50%	-50.84%	25.56%	971.73%	60.24%	23.23%	Upgrade
EPS (Basic)	1.29	-1.80	-0.22	-0.27	-2.45	-4.23	Upgrade
EPS (Diluted)	1.29	-1.80	-0.22	-0.27	-2.45	-4.23	Upgrade
EBIT	-4.5	-6.52	-6.46	-4.39	-3.62	-3.83	Upgrade

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q